IMMUNE CHECKPOINT INHIBITOR
Clinical trials for IMMUNE CHECKPOINT INHIBITOR explained in plain language.
Never miss a new study
Get alerted when new IMMUNE CHECKPOINT INHIBITOR trials appear
Sign up with your email to follow new studies for IMMUNE CHECKPOINT INHIBITOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
AI vs. liver cancer: can computers pick who needs treatment?
Disease control Not yet recruitingThis study aims to see if an artificial intelligence (AI) model can better identify which liver cancer patients need immunotherapy after surgery to prevent the cancer from coming back. It will follow 300 patients who have had their liver tumors surgically removed. The AI will ana…
Matched conditions: IMMUNE CHECKPOINT INHIBITOR
Sponsor: Tongji Hospital • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC
-
Fungus-Based pill joins forces with radiation to fight tough cancers
Disease control Not yet recruitingThis study is testing a combination treatment for people with advanced solid tumors that have spread or returned. It combines a pill made from a natural fungus compound (PRaG-1) with targeted radiation, immune-boosting injections, and standard immunotherapy drugs. The main goal i…
Matched conditions: IMMUNE CHECKPOINT INHIBITOR
Phase: PHASE2 • Sponsor: Second Affiliated Hospital of Soochow University • Aim: Disease control
Last updated Mar 11, 2026 14:54 UTC
-
Do painkillers weaken cancer treatment? new study investigates
Knowledge-focused Not yet recruitingThis study aims to understand if how well pain is controlled, and the use of opioid pain medications, affects how well immunotherapy works for people with advanced lung cancer. It will observe 100 adult patients who have cancer pain and are receiving immunotherapy. The goal is to…
Matched conditions: IMMUNE CHECKPOINT INHIBITOR
Sponsor: Hubei Cancer Hospital • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:28 UTC